Accelerate Diagnostics, Inc. (LON:0H8E)
0.0126
+0.0001 (0.80%)
At close: May 22, 2025
Accelerate Diagnostics Employees
Accelerate Diagnostics had 107 employees as of December 31, 2024. The number of employees decreased by 27 or -20.15% compared to the previous year.
Employees
107
Change (1Y)
-27
Growth (1Y)
-20.15%
Revenue / Employee
87.33K GBP
Profits / Employee
-373.59K GBP
Market Cap
103.99K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,382 |
Accelerate Diagnostics News
- 2 months ago - Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets - PRNewsWire
- 3 months ago - Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance - PRNewsWire
- 3 months ago - Accelerate Diagnostics reports Q4 results - Seeking Alpha
- 3 months ago - Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results - PRNewsWire
- 6 months ago - Accelerate Diagnostics reports preliminary FY 2024 revenue of $11.7 million - Seeking Alpha
- 6 months ago - Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results - PRNewsWire
- 6 months ago - GRIFFIN ASSET MANAGEMENT, INC. Reduces Holdings in Accelerate Diagnostics Inc - GuruFocus
- 8 months ago - Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript - Seeking Alpha